BIIB

Biogen
D

BIIB

Arincen57/100B
251.410
USD
0.89
(0.36%)
Market Open
Last updated: · Delayed 15 min
Fair value393.61Plus-36%295Price 251.41492
Q4 FY2026 · Earnings report
EPS estimate 2.81Revenue estimate 2.61B
OverviewFinancialsForecastEarningsCompany

Biogen net income 1985–2026

Biogen lost 20.60M USD in Q3 FY2026, the three months to 30 September 2026, down 104.4% on the same quarter a year before. Biogen's net income over the last twelve months was 347.50M USD, down 78.4% on the twelve months before. In fiscal year 2025 it earned 1.29B USD, down 20.8% on the year before.

Last updated 9 Nov 2026 · Next report 5 Feb 2027

Net income

Net income · -9.6% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 2026347.50M-78.40%3.37%10.30B
FY202531 Dec 20251.29B-20.76%13.08%9.89B
FY202431 Dec 20241.63B+40.57%16.87%9.68B
FY202331 Dec 20231.16B-61.89%11.81%9.84B
FY202231 Dec 20223.05B+95.80%29.95%10.17B
FY202131 Dec 20211.56B-61.10%14.17%10.98B
FY202031 Dec 20204.00B-32.06%29.76%13.44B
FY201931 Dec 20195.89B+32.90%40.96%14.38B
FY201831 Dec 20184.43B+74.50%32.93%13.45B
FY201731 Dec 20172.54B-31.43%20.69%12.27B
FY201631 Dec 20163.70B+4.39%32.34%11.45B
FY201531 Dec 20153.55B+20.86%32.95%10.76B
FY201431 Dec 20142.93B+57.59%30.25%9.70B
FY201331 Dec 20131.86B+34.95%26.86%6.93B
FY201231 Dec 20121.38B+11.80%25.02%5.51B
FY201131 Dec 20111.23B+22.80%24.45%5.05B
FY201031 Dec 20101.01B+3.62%21.31%4.72B
FY200931 Dec 2009970.13M+23.87%22.16%4.38B
FY200831 Dec 2008783.17M+22.72%19.11%4.10B
FY200731 Dec 2007638.17M+193.40%20.12%3.17B
FY200631 Dec 2006217.51M+35.34%8.11%2.68B
FY200531 Dec 2005160.71M+540.64%9.38%1.71B
FY200431 Dec 200425.09M—1.57%1.60B
FY200331 Dec 2003-875.10M-690.92%-470.14%186.13M
FY200231 Dec 2002148.09M-45.69%36.64%404.22M
FY200131 Dec 2001272.68M-18.25%26.16%1.04B
FY200031 Dec 2000333.58M+51.32%36.04%925.67M
FY199931 Dec 1999220.45M+58.94%27.75%794.44M
FY199831 Dec 1998138.70M+55.55%24.87%557.59M
FY199731 Dec 199789.17M+120.00%20.54%434.04M
FY199631 Dec 199640.53M+616.08%14.63%277.09M
FY199531 Dec 19955.66M—3.73%151.69M
FY199431 Dec 1994-4.90M-115.11%-3.13%156.34M
FY199331 Dec 199332.40M-15.40%23.75%136.40M
FY199231 Dec 199238.30M+431.94%30.96%123.70M
FY199131 Dec 19917.20M-6.49%11.73%61.40M
FY199031 Dec 19907.70M+140.63%15.37%50.10M
FY198931 Dec 19893.20M—11.23%28.50M
FY198831 Dec 1988-1.20M—-5.83%20.60M
FY198731 Dec 1987-22.60M—-262.79%8.60M
FY198631 Dec 1986-28.20M—-440.63%6.40M
FY198531 Dec 1985-19.10M—-126.49%15.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Biogen's profit

Source: Financial Modeling Prep